NUTRITIONAL STATUS AND METABOLIC SYNDROME AMONG OUTPATIENTS WITH TYPE 2 DIABETES AT NAM DINH MEDICAL CENTER IN 2025
Main Article Content
Abstract
Aims: To assess the nutritional status and describe the prevalence of metabolic syndrome (MetS) among patients with type 2 diabetes at Nam Dinh Medical Center in 2025.
Methods: A cross-sectional study was conducted among 205 patients with type 2 diabetes. Participants were interviewed directly using a structured questionnaire to collect information on general characteristics, anthropometric measurements, and blood pressure indicators. Biochemical parameters were obtained from the participants’ blood test results at Nam Dinh Medical Center. Nutritional status was classified according to body mass index (BMI). Factors associated with metabolic syndrome were identified using multivariable logistic regression analysis.
Results: The prevalence of overweight was 37.1%, while chronic energy deficiency was 8.8%. The prevalence of metabolic syndrome was 65.4%. Age ≥60 years, overweight/obesity, and a duration of diabetes ≥5 years were significantly associated with metabolic syndrome (p < 0.05). In multivariable analysis, only overweight/obesity remained independently associated with metabolic syndrome (OR = 2.85; 95% CI: 1.50–5.40; p = 0.001).
Conclusion: Overweight is highly prevalent among patients with type 2 diabetes. Metabolic syndrome is common in this population and is strongly associated with overweight/obesity, older age, and longer disease duration. Strengthening the screening and management of metabolic risk factors is essential to reduce the risk of complications.
Keywords
: metabolic syndrome, type 2 diabetes, related factors, nutritional status
Article Details
References
2. Irini Genitsaridi, Paraskevi Salpea, Salim A, Seyedeh Forough Sajjadi, Tomic D, James S, et al.. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol. 2026;14(2):149–56. doi:10.1016/S2213-8587(25)00299-2.
3. Vũ Thị Lan Phương, Nguyễn Trọng Hưng, Phan Hướng Dương, Nguyễn Thị Lan Hương. Hội chứng chuyển hóa ở người bệnh đái tháo đường típ 2 điều trị nội trú tại Bệnh viện Nội tiết Trung ương, năm 2019–2020. Tạp chí Dinh dưỡng và Thực phẩm. 29/4/2022;16(2):111–8.
4. Trần Văn Được, et al. Hội chứng chuyển hóa và một số yếu tố liên quan ở người bệnh đái tháo đường típ 2 điều trị ngoại trú tại Bệnh viện đa khoa khu vực Ngọc Hồi năm 2024. Có sẵn tại: https://bvdkkvnhkt.org.vn/hoat-dong/nghien-cuu-khoa-hoc/hoi-chung-chuyen-hoa-va-mot-so-yeu-to-lien-quan-o-nguoi-benh-dai-thao-duong-tip-2-dieu-tri-ngoai-tru-tai-benh-vien-da-kh.html
5. Hoàng Thị Thu Hằng và cs. Hội chứng chuyển hóa và một số yếu tố liên quan ở người bệnh đái tháo đường típ 2 tại Bệnh viện 19-8 (2024–2025). Tài liệu Hội nghị Khoa học Dinh dưỡng Toàn quốc; 2025.
6. World Health Organization. WHO STEPwise approach to noncommunicable disease risk factor surveillance (STEPS): manual. Geneva: World Health Organization; 2017. Available from: https://www.who.int/ncds/surveillance/steps
7. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: International Diabetes Federation; 2005. Available from: https://www.idf.org
8. Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the Asia-Pacific region: a systematic review. BMC Public Health. 2017 Jan 21;17(1):101. doi:10.1186/s12889-017-4041-1.
9. Dang AK, et al. Prevalence of metabolic syndrome and its related factors among Vietnamese people: a systematic review and meta-analysis. Diabetes Metab Syndr. 2022 Apr;16(4):102477. doi:10.1016/j.dsx.2022.102477.
10.World Health Organization. Obesity and overweight. Geneva: World Health Organization; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight